[1]王 坤,张永春.血清胆红素水平、单核细胞数、红细胞分布宽度与 冠状动脉病变程度的关系[J].医学信息,2018,31(08):53-56.[doi:10.3969/j.issn.1006-1959.2018.08.017]
　WANG Kun,ZHANG Yong-chun.Relationship between Serum Bilirubin Level,Monocyte Count,Red Blood Cell Distribution Width and Severity of Coronary Artery Disease[J].Journal of Medical Information,2018,31(08):53-56.[doi:10.3969/j.issn.1006-1959.2018.08.017]
点击复制

血清胆红素水平、单核细胞数、红细胞分布宽度与 冠状动脉病变程度的关系()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年08期
页码:
53-56
栏目:
论著
出版日期:
2018-04-15

文章信息/Info

Title:
Relationship between Serum Bilirubin Level,Monocyte Count,Red Blood Cell Distribution Width and Severity of Coronary Artery Disease
文章编号:
1006-1959（2018）08-0053-04
作者:
王 坤; 张永春
新乡医学院第一附属医院心血管内科，河南 新乡 453100
Author(s):
WANG Kun; ZHANG Yong-chun
Department of Cardiovascular Medicine,First Affiliated Hospital of Xinxiang Medical College,Xinxiang 453100,Henan,China
关键词:
冠心病; 血清胆红素水平; 单核细胞数; 红细胞分布宽度
Keywords:
Key words：Coronary heart disease; Serum bilirubin levels; Monocyte count; Erythrocyte distribution width
分类号:
R446.11
DOI:
10.3969/j.issn.1006-1959.2018.08.017
文献标志码:
A
摘要:
目的 探讨血清总胆红素、直接胆红素、间接胆红素、单核细胞数、红细胞分布宽度与冠状动脉病变程度的关系。方法 选取2016年3月~2017年1月新乡医学院第一附属医院收治的247例拟诊冠心病(CHD)患者，检测外周血TBi L、DBi L、IBi L、Mon、RDW水平，依据冠状动脉造影结果采用Gensini积分法对拟诊冠心病患者进行分组，比较不同冠状动脉病变程度患者之间TBi L、DBi L、IBi L、Mon、RDW水平的差异。结果 冠状动脉病变组患者TBi L、DBi L、IBi L低于正常组，统计学意义显著（P＜0.01），Mon、RDW高于正常组，统计学意义显著（P＜0.01）。冠状动脉病变组中，与冠状动脉轻度、中度病变患者相比，冠状动脉重度病变患者，血清TBi L、DBi L、IBi L水平最低，差异有统计学意义（P＜0.05），Mon、RDW水平最高，差异有统计学意义（P＜0.05）,但中度病变组患者Mon、RDW与轻度病变组比较，差异无统计学意义（P＞0.05）。结论 血清胆红素、单核细胞数、RDW可作为CHD的危险因素，对预测CHD的发生及评估冠状动脉病变程度有重要参考价值。
Abstract:
Abstract：Objective To investigate the relationship between serum total bilirubin,direct bilirubin,indirect bilirubin,monocyte number, erythrocyte distribution width and severity of coronary artery disease.Methods From March 2016 to January 2017,247 patients with coronary heart disease(CHD)admitted in the first affiliated Hospital of Xinxiang Medical College were selected,peripheral blood levels of TBi L,DBi L,IBi L,Mon,and RDW were measured and Gensini scores were used to classify patients with suspected coronary artery disease according to coronary angiographic results.Patients with different coronary artery disease were compared for TBi L and DBi L. Differences in IBi L,Mon,and RDW levels.Results The TBi L,DBi L and IBi L in the patients with coronary artery disease were significantly lower than those of the normal group,the difference was statistically significant(P<0.01),Mon and RDW were higher than those of the normal group,with significant difference(P<0.01).In the coronary artery disease group,the serum levels of TBi L,DBi L,and IBi L were the lowest in patients with severe coronary artery disease compared with those with mild or moderate coronary disease(P<0.05).The level of Mon and RDW was the highest,and the difference was statistically significant(P<0.05),but there was no significant difference in Mon,RDW and mild lesions in the moderate lesion group,the difference was not statistically significant(P>0.05). Conclusion Serum bilirubin,mononuclear cell number and RDW can be used as a risk factor for CHD,which is of important reference value for predicting the occurrence of CHD and assessing the degree of coronary artery disease.

参考文献/References:

[1]杨秀秀,苏工.2型糖尿病患者血糖变异性与冠状动脉病变程度之间的关系[J].心肺血管病杂志,2017,36(06):440-443.
[2]Haghdoost F,Javanmard SH,Keyhanian K,et al.Association of heme oxygenase-1 gene promoter polymorphism and blood pressure in an Iranian population[J].Intern Med J,2014,44(9):931-932.
[3]Rogacev K S,Cremers B,Zawada A M,et al.CD14+CD16+ monocytes independently predict cardiovascular events:a cohort study of 951 patients referred for elective coronary angiography[J].Journal of the American College of Cardiology,2012,60(16):1512.
[4]Magri C J,Tian T X,Camilleri L,et al.Red blood cell distribution width and myocardial scar burden in coronary artery disease[J].Postgraduate Medical Journal,2017.93(1104):607-612.
[5]杜玥,雷红.血小板/淋巴细胞比值与冠状动脉狭窄程度的关系探讨[J].中西医结合心脑血管病杂志,2015,13(18):2103-2106.
[6]Gensini G G.Gensini GG.A more meaningful scoring system for determining the severity of coronary heart disease[J].American Journal of Cardiology,1983,51(3):606.
[7]Pr DSN,Kusters DM,Hutten B A,et al.Serum bilirubin levels in familial hypercholesterolemia:A new risk marker for cardiovascular disease[J].Journal of Lipid Research,2011,52(9):1755-1759.
[8]Violi F,Pignatelli P.Clinical Application of NOX Activity and Other Oxidative Biomarkers in Cardiovascular Disease:A Critical Review[J].Antioxidants&Redox Signaling,2015,23(5):514.
[9]Kunutsor S K,Bakker S J,Gansevoort RT,et al.Circulating Total Bilirubin and Risk of Incident Cardiovascular Disease in the General Population[J].Arteriosclerosis Thrombosis&Vascular Biology,2015,35(3):716.
[10]Jansen T,Hortmann M,Oelze M,et al.Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin[J].Journal of Molecular&Cellular Cardiology,2010,49(2):186.
[11]Akboga MK,Canpolat U,Sahinarslan A,et al.Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation[J].Atherosclerosis,2015,240(1):110-114.
[12]Jetten N,Verbruggen S,Gijbels M J,et al.Anti-inflammatory M2,but not pro-inflammatory M1 macrophages promote angiogenesis in vivo[J].Angiogenesis,2014,17(1):109-118.
[13]Ghattas A,Griffiths H R,Devitt A,et al.Monocytes in Coronary Artery Disease and Atherosclerosis:Where Are We Now[J].Journal of the American College of Cardiology,2013,62(17):1541.
[14]Asli T,Asife S,Sehri E,et al.Relationship Between MMP-1, MMP-9,TIMP-1,IL-6 and Risk Factors,Clinical Presentation,Extent and Severity of Atherosclerotic Coronary Artery Disease[J].Open Cardiovascular Medicine Journal,2011(5):110-116.
[15]Lippi G,Targher G,Montagnana M,et al.Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients[J].Archives of Pathology&Laboratory Medicine,2009,133(4):628.
[16]Vaya A,Hernández J L,Zorio E,et al.Association between red blood cell distribution width and the risk of future cardiovascular events[J].Clinical Hemorheology&Microcirculation,2012,50(3):221.

相似文献/References:

[1]袁 帅,邢晓博,李 晓,等.MTHFR基因多态性与中年男性冠状动脉病变程度的相关研究[J].医学信息,2018,31(03):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
　YUAN Shuai,XING Xiao-bo,LI Xiao,et al.Association of MTHFR Gene Polymorphism with Coronary Artery Lesions in Middle-aged Men[J].Journal of Medical Information,2018,31(08):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
[2]张挺挺.经股和桡动脉介入治疗冠心病的临床疗效对比[J].医学信息,2018,31(03):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
　ZHANG Ting-ting.Comparison of Clinical Effects of Interventional Treatment of Coronary Heart Disease by Femoral and Radial Artery[J].Journal of Medical Information,2018,31(08):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
[3]迮艳华.稳心颗粒联合美托洛尔治疗冠心病心律失常的疗效分析[J].医学信息,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
　ZE Yan-hua.Therapeutic Effect of Wenxin Granule Combined with Metoprolol on Arrhythmia of Coronary Heart Disease[J].Journal of Medical Information,2018,31(08):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
[4]张 旭.冠心病心绞痛患者进行护理干预的临床效果及 对护理质量影响研究[J].医学信息,2018,31(05):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
　ZHANG Xu.Clinical Effect of Nursing Intervention in Patients with Angina Pectoris of Coronary Heart Disease and its Influence on Nursing Quality[J].Journal of Medical Information,2018,31(08):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
[5]向明明,赵晓辉.黑龙江省东部地区汉族人群冠心病的危险因素研究[J].医学信息,2018,31(07):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
　XIANG Ming-ming,ZHAO Xiao-hui.Study on Risk Factors of Coronary Heart Disease in Han Nationality Population in Eastern Heilongjiang Province[J].Journal of Medical Information,2018,31(08):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
[6]毛红岩.冠状动脉介入治疗冠心病的疗效及 对患者血清炎症因子的影响[J].医学信息,2018,31(10):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
　MAO Hong-yan.Effect of Coronary Intervention on Coronary Heart Disease and its Influence on Serum Inflammatory Factors[J].Journal of Medical Information,2018,31(08):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
[7]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与 冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
　YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Journal of Medical Information,2018,31(08):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[8]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
　LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Journal of Medical Information,2018,31(08):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[9]田跃雷.冠心病介入治疗后再狭窄的中西医防治[J].医学信息,2022,35(09):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
　TIAN Yue-lei.Prevention and Treatment of Restenosis After Percutaneous Coronary Intervention with Chinese and Western Medicine[J].Journal of Medical Information,2022,35(08):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
[10]宫丽萍.血府逐瘀汤加减治疗气滞血瘀型冠心病心绞痛的疗效研究[J].医学信息,2018,31(12):145.[doi:10.3969/j.issn.1006-1959.2018.12.046]
　GONG Li-ping.Therapeutic Effect of Xuefu Zhuyu Decoction on Angina Pectoris with Qi Stagnation and Blood Stasis[J].Journal of Medical Information,2018,31(08):145.[doi:10.3969/j.issn.1006-1959.2018.12.046]

更新日期/Last Update: 2018-04-15